This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Catherine McKeen
Senior Director of R&D, Nucleic Acid Chemistries and Oligonucleotides at LGC, Biosearch Technologies
Speaker

Profile

Catherine has over 30 years’ experience in the oligonucleotide and oligo reagent market with senior roles across Operations, Business Development and NPD. After a PhD at Heriot-Watt University, she worked with Prof. Tom Brown at the University of Edinburgh and at his company, Oswel Research Products, designing and manufacturing new synthesis reagents and oligos. After Eurogentec’s acquisition of Oswel, she moved into Production and Operations Management. She later joined Link Technologies, which was acquired by LGC and integrated into Biosearch Technologies.

Agenda Sessions

  • Improving siRNA Yield and Manufacturing Performance with PrimeMax™ CPG

    1:35pm